Technology | Advanced Visualization | February 27, 2019

Philips Introduces IntelliSpace Portal 11 at ECR 2019

Latest release of Philips advanced visualization platform builds on intelligent clinical applications, hospital network connectivity and patient data security

Philips Introduces IntelliSpace Portal 11 at ECR 2019

February 27, 2019 — Philips announced the launch of IntelliSpace Portal 11, the latest release of the company’s comprehensive, advanced visualization and quantification software. Launching at the 2019 European Congress of Radiology (ECR), Feb. 27-March 3 in Vienna, Austria, the new version further extends the clinical innovation of the portal, with enhancements to improve workflow efficiencies, bridging secure data sharing between systems within the hospital network to address the security and privacy needs of customers globally.

Philips IntelliSpace Portal is an advanced visualization and analysis software solution designed to support diagnostic process, follow-up and communication across clinical domains and modalities, through a connected and secure workflow. The solution is a multimodality and multivendor comprehensive suite of advanced visualization solutions for radiology. It can scale to fit large scale enterprises, helping to maximize resources by leveraging analytical tools.

Philips IntelliSpace Portal 11 offers a seamless integrated portfolio of clinically rich applications for neurology, oncology and cardiology domains. The new version is focused on enhancing clinical workflow and automation via adaptive intelligence (aka artificial intelligence, or AI) functionalities, combining clinical data from multimodalities across the health continuum. The latest iteration also includes a new integrated Nuclear Medicine Viewer by Mirada Medical designed to support clinical challenges and productivity, with a dedicated optimized workflow for quantitative patient follow-up.

IntelliSpace Portal 11 introduces new zero-footprint viewer capabilities running directly through a web browser to provide anywhere access to advanced visualization data review during multi-disciplinary meetings inside or outside the hospital. Users can consult and share findings online with real-time peer to peer interaction. The viewer also offers scalability from a single department to an enterprise-wide solution. Philips noted that the zero-footprint viewer is not intended for diagnostic review.

Supporting patient data confidentiality, integrity and availability are part of the IntelliSpace Portal 11 security policy. The solution can be tailored to the customer environment, allowing flexible settings for patient and role-based access controls, designed to protect sensitive data from unauthorized access.

For more information: www.usa.philips.com/healthcare

Related Content

The U.S. Food and Drug Administration (#FDA) authorized marketing of #Medtronic's #GIGenius, the first device that uses #artificialintelligence (#AI) based on #machinelearning to assist #clinicians in detecting #lesions (such as #polyps or suspected tumors) in the #colon in real time during a c#olonoscopy.

The GI Genius intelligent endoscopy module works in real-time, automatically identifying and marking (with a green box) abnormalities consistent with colorectal polyps, including small flat polyps.

News | Artificial Intelligence | April 12, 2021
Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation — a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.
News | Artificial Intelligence | April 08, 2021
April 8, 2021 — Varian announced it is collaborating with Google...
Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

News | Artificial Intelligence | April 07, 2021
April 7, 2021 — Vysioneer, a leader in a...
Axial chest CT examination in a 54-year-old participant. A, On the axial noncontrast chest CT image, the pectoralis muscle (PM) area was segmented and measured in the section above the aortic arch. B, The subcutaneous adipose tissue (SAT) area as the area between the PM and the skin surface on the same section was also measured and the attenuation of pixels in the SAT area was used to determine the individualized threshold for the intermuscular adipose tissue (IMAT). C, The IMAT within the PM was segmented

Axial chest CT examination in a 54-year-old participant. A, On the axial noncontrast chest CT image, the pectoralis muscle (PM) area was segmented and measured in the section above the aortic arch. B, The subcutaneous adipose tissue (SAT) area as the area between the PM and the skin surface on the same section was also measured and the attenuation of pixels in the SAT area was used to determine the individualized threshold for the intermuscular adipose tissue (IMAT). C, The IMAT within the PM was segmented as the areas with Hounsfield units below this threshold for the IMAT (arrowheads). Image courtesy of the Radiological Society of North America

News | Computed Tomography (CT) | April 07, 2021
April 7, 2021 — Body composition information derived from routine chest...
Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

News | Artificial Intelligence | April 06, 2021
April 6, 2021 — In 2020, the International Agency for Research on...
Nano-X Imaging Ltd (Nanox), an innovative medical imaging technology company, announced that its single-source Nanox.ARC digital x-ray technology has received 510(k) clearance from the US Food and Drug Administration.
News | X-Ray | April 02, 2021
April 2, 2021 — Nano-X Imaging Ltd.